Application

17041703 · Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy

Filed 2020-09-25 · Granted · Patent 12285410 (2025-04-29) The official file ↗The patent and its PDF ↗ · Art unit 1623 · Examiner Samantha L Shterengarts Easy · CPC A61K 31/4155 · 4SC AG · MILLEN, WHITE, ZELANO & BRANIGAN, P.C.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

36.1 mo

to disposition 55.1 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.